Status:
RECRUITING
Sarcopenia in Gestational Diabetes
Lead Sponsor:
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche
Collaborating Sponsors:
University of Pisa
Medical University of Vienna
Conditions:
Sarcopenia
Gestational Diabetes Mellitus (GDM)
Eligibility:
FEMALE
35+ years
Brief Summary
Sarcopenia is a syndrome characterized by loss of skeletal muscle mass and strength, and physical performance deterioration. Prevalence of sarcopenia in elderly people is remarkably high (prevalence o...
Eligibility Criteria
Inclusion
- At least one among the following conditions:
- Age equal to or higher than 35 years;
- Body mass index (BMI) equal to or higher than 25 kg/m\^2;
- Glycemia between 5.6 and 6.9 mmol/L before or at the beginning of pregnancy;
- Fetal macrosomia in previous pregnancy;
- GDM in previous pregnancy;
- First-degree family history of diabetes.
Exclusion
- Unmatching of at least one among the inclusion criteria;
- Twin pregnancy;
- Presence of any already known disease/disorder possibly affecting muscle mass or function;
- Neurological or psychiatric diseases;
- Already known diabetes (e.g., type 1 or type 2 diabetes).
Key Trial Info
Start Date :
May 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06876090
Start Date
May 28 2025
End Date
April 1 2026
Last Update
November 21 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynaecology, Division of Obstetrics and Feto-Maternal Medicine, Medical University of Vienna, Vienna
Vienna, Austria, 1090
2
Institute of Neuroscience, National Research Council
Padua, PD, Italy, 35127
3
Department of Clinical and Experimental Medicine, University of Pisa
Pisa, PI, Italy, 56124